Elagolix

Elagolix (ABT-620) is an oral gonadotropin-releasing hormone antagonist being studied for the treatment of endometriosis, uterine fibroids and PCOS.

Type of Molecule

Small Molecule

Target

GnRH

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Endometriosis US
Approved
Uterine Fibroids n/a
Phase 3
PCOS n/a
Phase 2